SPRO – spero therapeutics, inc. (US:NASDAQ)
Stock Stats
News
1/30
08:18 am
spro
Low
Spero Therapeutics, Inc. (NASDAQ: SPRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
1/10
07:26 am
spro
Low
Spero Therapeutics names Esther Rajavelu as Interim President and CEO [Seeking Alpha]
1/10
07:00 am
spro
Low
Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes
12/20
08:09 am
spro
Medium
Spero Therapeutics, Inc. (NASDAQ: SPRO) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "in-line" rating. They now have a $5.00 price target on the stock.
12/16
08:24 pm
spro
Medium
Spero Therapeutics (SPRO) Loses -9.32% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]
11/14/2024
04:05 pm
spro
-5.6%
MISS
8/5/2024
04:01 pm
spro
-5.2%
BEAT
5/15/2024
04:05 pm
spro
1.3%
MISS
3/13/2024
04:01 pm
spro
4.8%
BEAT
1/30
08:18 am
Reiterates
Buy
Buy
HC Wainwright
Low
2.3%
12/20
08:09 am
Downgrades
Outperform
In-Line
Evercore ISI
Medium
-3.5%
12/20
08:09 am
Downgrades
Outperform
In-Line
Evercore ISI
Medium
-3.5%
12/20
06:38 am
Downgrades
Outperform
In-Line
Evercore ISI Group
Medium
-4.3%
12/20
05:42 am
Downgrades
OUTPERFORM
IN LINE
EVERCORE ISI
Medium
-4.3%
2/5
09:05 pm
spro
Low
Form 4 Spero Therapeutics, Inc. For: Feb 03 Filed by: Keutzer Timothy
2/5
08:53 pm
spro
Low
Form 4 Spero Therapeutics, Inc. For: Feb 03 Filed by: Rajavelu Esther
2/5
08:32 pm
spro
Low
Form 4 Spero Therapeutics, Inc. For: Feb 03 Filed by: Shukla Sath
2/5
08:30 pm
spro
Low
Form 4 Spero Therapeutics, Inc. For: Feb 05 Filed by: Mahadevia Ankit
1/10
07:02 am
spro
Medium
Form 8-K Spero Therapeutics, Inc. For: Jan 07
Show more
Top News Gainers
6/13 Spero Announces $10 Million Registered Direct Offering of Common Stock 22.4%
3/17 Spero Therapeutics Inc (NASDAQ: SPRO) had its price target lowered by analysts at Stifel Nicolaus from $22.00 to $21.00. They now have a "buy" rating on the stock. 21.5%
5/9 Q1/2019 3/31/2019 EPS -0.290 ZacksConsensus -0.760 ActVsEst 0.470 - Beat 11.5%
9/9 Spero Therapeutics Inc (NASDAQ: SPRO) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating on the stock. 11.0%
8/16 Spero Therapeutics Inc (NASDAQ: SPRO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.0%
6/17 Spero Therapeutics to Present Data for All Pipeline Programs at the ASM Microbe 2019 Conference 5.8%
6/20 Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research Institute to Develop SPR720 for Tuberculosis 5.7%
9/10 Spero Therapeutics Inc (NASDAQ: SPRO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 5.4%
2/3 Form 4 Spero Therapeutics, Inc. For: Feb 03 Filed by: Keutzer Timothy 5.4%
10/16 Spero Therapeutics Inc (NASDAQ: SPRO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 4.9%
Top News Decliners
3/19 Form S-8 Spero Therapeutics, Inc. -26.1%
3/16 Form 10-K Spero Therapeutics, Inc. For: Dec 31 -18.7%
6/27 Spero Therapeutics Inc (NASDAQ: SPRO) was upgraded by analysts at TheStreet from a "d" rating to a "c-" rating. -13.3%
3/11 Spero Therapeutics Receives FDA Orphan Drug Designation for SPR720 for the Treatment of Nontuberculous Mycobacterial (NTM) Infection -11.9%
2/28 Form 8-K Spero Therapeutics, Inc. For: Feb 28 -7.8%
3/31 Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -7.8%
4/30 Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -6.3%
4/15 Spero Therapeutics Inc (NASDAQ: SPRO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.75 price target on the stock. -4.4%
9/26 Spero Therapeutics Announces Presentations at IDWeek 2019 -4.1%
2/14 Form SC 13G/A Spero Therapeutics, Inc. Filed by: Aquilo Capital Management, LLC -4.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3